NCT03147534 (CIT-CRCP) is a NA clinical trial of InstaTemp MD in Healthy, sponsored by ARC Devices.

Who is sponsoring NCT03147534?

NCT03147534 is sponsored by ARC Devices.

What drugs are being tested in NCT03147534?

Interventions in NCT03147534: InstaTemp MD, "Welch Allyn", rectal, "Welch Allyn", oral, Covidien, tympanic.

What condition does NCT03147534 study?

NCT03147534 studies Healthy, Febrile Illness.

Is NCT03147534 still recruiting?

NCT03147534 is currently withdrawn. Last updated 14 January 2021.

Last reviewed 2021-01-14 · How we verify

NCT03147534: CIT-CRCP

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Comparison of Thermometry in Canada for Pediatrics

Withdrawn NA Last updated 14 January 2021

What this trial tests

NA trial testing InstaTemp MD in Healthy. Withdrawn.

Timeline

1 February 2017

Primary endpoint
8 May 2018

8 May 2018

Quick facts

Lead sponsor	ARC Devices
Phase	NA
Status	Withdrawn
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	other
Start date	1 February 2017
Primary completion	8 May 2018
Estimated completion	8 May 2018
Sites	2 locations across Canada

Drugs / interventions tested

InstaTemp MD
"Welch Allyn", rectal
"Welch Allyn", oral
Covidien, tympanic

Conditions studied

Healthy — all drugs for Healthy →
Febrile Illness — all drugs for Febrile Illness →

Sponsor

ARC Devices

Who can join

Adults 1 Month to 10, any sex, with Healthy or Febrile Illness. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Compare and assess the accuracy and reliability of the InstaTemp MD® device to techniques presently in use for measuring temperature in infants and children in a Canadian clinical setting.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Healthy

Currently open trials in the same condition.

NCT06707207 — Predicting Future Errors During Skill Performance · recruiting
NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease. · NA · recruiting
NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects · NA · recruiting
NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity · Phase 1, PHASE2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03147534 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by ARC Devices
Last refreshed: 14 January 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03147534.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing